Compare ATEC & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATEC | PRGO |
|---|---|---|
| Founded | 1990 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 2006 | 1991 |
| Metric | ATEC | PRGO |
|---|---|---|
| Price | $13.90 | $14.64 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 3 |
| Target Price | ★ $22.36 | $20.33 |
| AVG Volume (30 Days) | ★ 4.2M | 2.3M |
| Earning Date | 02-24-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 7.92% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $728,020,000.00 | ★ $4,281,800,000.00 |
| Revenue This Year | $27.10 | N/A |
| Revenue Next Year | $16.77 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 27.11 | N/A |
| 52 Week Low | $8.81 | $12.17 |
| 52 Week High | $23.29 | $30.93 |
| Indicator | ATEC | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 26.75 | 47.75 |
| Support Level | $13.43 | $14.13 |
| Resistance Level | $15.55 | $14.82 |
| Average True Range (ATR) | 0.70 | 0.53 |
| MACD | -0.15 | -0.04 |
| Stochastic Oscillator | 6.91 | 37.33 |
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.